- Home
- FULC vs NHS Comparison
FULC vs NHS Comparison
Compare FULC & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- NHS
- Stock Information
- Founded
- FULC 2015
- NHS 2003
- Country
- FULC United States
- NHS United States
- Employees
- FULC N/A
- NHS N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- NHS Trusts Except Educational Religious and Charitable
- Sector
- FULC Health Care
- NHS Finance
- Exchange
- FULC Nasdaq
- NHS Nasdaq
- Market Cap
- FULC 221.5M
- NHS 221.6M
- IPO Year
- FULC 2019
- NHS N/A
- Fundamental
- Price
- FULC $3.96
- NHS $7.57
- Analyst Decision
- FULC Hold
- NHS
- Analyst Count
- FULC 10
- NHS 0
- Target Price
- FULC $7.44
- NHS N/A
- AVG Volume (30 Days)
- FULC 1.0M
- NHS 111.8K
- Earning Date
- FULC 02-25-2025
- NHS 01-01-0001
- Dividend Yield
- FULC N/A
- NHS 13.44%
- EPS Growth
- FULC N/A
- NHS N/A
- EPS
- FULC N/A
- NHS N/A
- Revenue
- FULC $80,871,000.00
- NHS N/A
- Revenue This Year
- FULC $2,821.96
- NHS N/A
- Revenue Next Year
- FULC N/A
- NHS N/A
- P/E Ratio
- FULC N/A
- NHS N/A
- Revenue Growth
- FULC 2987.86
- NHS N/A
- 52 Week Low
- FULC $2.86
- NHS $6.95
- 52 Week High
- FULC $13.70
- NHS $9.17
- Technical
- Relative Strength Index (RSI)
- FULC 41.64
- NHS 42.83
- Support Level
- FULC $3.93
- NHS $7.51
- Resistance Level
- FULC $5.17
- NHS $7.61
- Average True Range (ATR)
- FULC 0.30
- NHS 0.10
- MACD
- FULC -0.13
- NHS 0.01
- Stochastic Oscillator
- FULC 3.97
- NHS 24.32
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.